Your shopping cart is currently empty

Biotin-COG1410 TFA is a biotinylated form of COG1410. COG1410 is a derivative peptide of apolipoprotein E and acts as an inhibitor of apoptosis. It exhibits neuroprotective and anti-inflammatory effects in a mouse traumatic brain injury (TBI) model. COG1410 is applicable for research in neurological disorders.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Biotin-COG1410 TFA is a biotinylated form of COG1410. COG1410 is a derivative peptide of apolipoprotein E and acts as an inhibitor of apoptosis. It exhibits neuroprotective and anti-inflammatory effects in a mouse traumatic brain injury (TBI) model. COG1410 is applicable for research in neurological disorders. |
| In vitro | Cog1410 (1-25 μm; 48 h) reduces the production and release of NO and TNFα in BV2 microglial cells. |
| In vivo | COG1410, administered as a single intravenous injection at doses of 0.3-0.6 mg/kg, significantly enhances short-term vestibular motor function and long-term spatial learning and memory in mice. At a dose of 0.8 mg/kg, COG1410 improves vestibular motor function in rats, reduces post-stroke motor asymmetry, and decreases the infarct volume in the ipsilateral hemisphere. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.